Skip to main content
. 2025 Jan 8;17(2):178. doi: 10.3390/cancers17020178
NAC Neoadjuvant Chemotherapy
TAD Targeted Axillary Dissection
ALND Axillary Lymph Node Dissection
SLNB Sentinel Lymph Node Biopsy
FNR False-Negative Rate
US Ultrasound
RT Radiotherapy
HER2 Human Epidermal Growth Factor Receptor 2
TNBC Triple-Negative Breast Cancer